These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8227492)

  • 21. Personality dimensions measured by the Temperament and Character Inventory (TCI) in subjects with social phobia.
    Marteinsdottir I; Tillfors M; Furmark T; Anderberg UM; Ekselius L
    Nord J Psychiatry; 2003; 57(1):29-35. PubMed ID: 12745789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-month outcome in bipolar patients with and without personality disorders.
    Dunayevich E; Sax KW; Keck PE; McElroy SL; Sorter MT; McConville BJ; Strakowski SM
    J Clin Psychiatry; 2000 Feb; 61(2):134-9. PubMed ID: 10732661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based pharmacotherapy for personality disorders.
    Ripoll LH; Triebwasser J; Siever LJ
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1257-88. PubMed ID: 21320390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer uses for older psychotropic medications.
    Liebowitz MR
    Hosp Community Psychiatry; 1982 Apr; 33(4):282-6. PubMed ID: 6122638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychopharmacology of borderline personality disorders.
    Montgomery SA
    Acta Psychiatr Belg; 1987; 87(3):260-6. PubMed ID: 3673629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic strategies for the patient with treatment-resistant anxiety.
    Coplan JD; Tiffon L; Gorman JM
    J Clin Psychiatry; 1993 May; 54 Suppl():69-74. PubMed ID: 8509358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships of neuroticism and extraversion with axis I and II comorbidity among patients with DSM-IV major depressive disorder.
    Jylhä P; Melartin T; Isometsä E
    J Affect Disord; 2009 Apr; 114(1-3):110-21. PubMed ID: 18687471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of axis II comorbidity in early-onset versus late-onset panic disorder in Japan.
    Iketani T; Kiriike N; Stein MB; Nagao K; Minamikawa N; Shidao A; Fukuhara H
    Compr Psychiatry; 2004; 45(2):114-20. PubMed ID: 14999662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analgesic abuse and psychiatric comorbidity in headache patients].
    Radat F; Irachabal S; Swendsen J; Henry P
    Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacotherapy of panic disorder].
    Bougerol T; Farisse J
    Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurrence of Axis I and Axis II disorders in female and male patients with panic disorder with agoraphobia.
    Starcevic V; Latas M; Kolar D; Vucinic-Latas D; Bogojevic G; Milovanovic S
    Compr Psychiatry; 2008; 49(6):537-43. PubMed ID: 18970901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopharmacologic treatment of panic, generalized anxiety disorder, and social phobia.
    Roy-Byrne P; Wingerson D; Cowley D; Dager S
    Psychiatr Clin North Am; 1993 Dec; 16(4):719-35. PubMed ID: 8309809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social phobia and avoidant personality disorder: one spectrum disorder?
    Tillfors M; Furmark T; Ekselius L; Fredrikson M
    Nord J Psychiatry; 2004; 58(2):147-52. PubMed ID: 15204221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do all personality disorders have in common? Ineffectiveness and uncooperativeness.
    Gutiérrez F; Navinés R; Navarro P; García-Esteve L; Subirá S; Torrens M; Martín-Santos R
    Compr Psychiatry; 2008; 49(6):570-8. PubMed ID: 18970905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special feature: pharmacotherapy in personality disorders.
    Kapfhammer HP; Hippius H
    J Pers Disord; 1998; 12(3):277-88. PubMed ID: 9785268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.